Variable Details
- Antihypertensive
- ACE inhibitors
- Angiotensin II receptor blockers
- Antiadrenergics
- Beta blocker medications
- Calcium chanel blocker medications
- Direct renin inhibitor medications
- Other antihypertensive medications
- Diuretic medications
- Pure diuretic medications
- Combination diuretic/hypertension medications
Available Studies
ROS, MAP, MARS, Clinical Core, LATC
Categories
Medications
Lipid-lowering
Lipid-lowering medication usage in last 2 weeks
Lipid-lowering medications are a group of any medications affecting cholesterol and are sub-categorized into statins and lipid-lowering nonstatins.
| Value | Coding |
|---|---|
| 1 | (Yes) If participant was taking a lipid-lowering medication at this visit |
| 0 | (No) If participant was not taking a lipid-lowering medication at this visit |
Participants supplied all medications prescribed by a doctor, vitamins, supplements, and over-the-counter remedies and medicines taken in the 2 weeks prior to the evaluation. Direct visual inspection of all containers of prescription and over-the-counter agents allowed for medication documentation. Medications were subsequently coded using the Medi-Span Drug Data Base system.
Medications include:
LIPITOR SIMVASTATIN ZOCOR
CRESTOR ATORVASTATIN LOVASTATIN
PRAVASTATIN ZETIA PRAVACHOL
VYTORIN MEVACOR TRICOR
LESCOL GEMFIBROZIL NIASPAN
FENOFIBRATE PRAVASTATIN CADUET
LESCOL XL WELCHOL LOVAZA
CHOLESTYRAMINE NIASPAN ER ATORVASTATIN CALCIUM
SIMVASTIN ADVICOR LOPID
LIPTOR ZOCAR PREVASTATIN
QUESTRAN TRILIPIX SIMVISTATIN
CHOLESTYRAMINE POWDER PREVALITE COLESTIPOL
NIACIN PRAVASTATIN NA COLESTID
PRAVACOL PROVASTATIN EZETIMIBE
Medi-Span. Master Drug Data Base Documentation Manual. Indianapolis, IN: Medi-Span, 1995.